NO975530L - Oksazolidinon derivater, deres fremstilling og terapeutiske anvendelse - Google Patents

Oksazolidinon derivater, deres fremstilling og terapeutiske anvendelse

Info

Publication number
NO975530L
NO975530L NO975530A NO975530A NO975530L NO 975530 L NO975530 L NO 975530L NO 975530 A NO975530 A NO 975530A NO 975530 A NO975530 A NO 975530A NO 975530 L NO975530 L NO 975530L
Authority
NO
Norway
Prior art keywords
preparation
therapeutic use
oxazolidinone derivatives
oxazolidinone
derivatives
Prior art date
Application number
NO975530A
Other languages
English (en)
Other versions
NO309091B1 (no
NO975530D0 (no
Inventor
Samir Jegham
Frederic Puech
Philippe Burnier
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26232004&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO975530(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from FR9506564A external-priority patent/FR2734821B1/fr
Priority claimed from FR9506563A external-priority patent/FR2734820B1/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO975530D0 publication Critical patent/NO975530D0/no
Publication of NO975530L publication Critical patent/NO975530L/no
Publication of NO309091B1 publication Critical patent/NO309091B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO975530A 1995-06-02 1997-12-01 Oksazolidinonderivater, deres fremstilling samt medikament og farmasøytisk preparat inneholdende disse NO309091B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9506564A FR2734821B1 (fr) 1995-06-02 1995-06-02 Derives de 5-methoxymethyl-3-(1,2-benzisoxazol-3-yl) oxazolidin-2-one, leur preparation et leur application en therapeutique
FR9506563A FR2734820B1 (fr) 1995-06-02 1995-06-02 Derives de 3-(1,2-benzisoxazol-3-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique
PCT/FR1996/000792 WO1996038444A1 (fr) 1995-06-02 1996-05-28 Derives d'oxazolidinone, leur preparation et leur application en therapeutique

Publications (3)

Publication Number Publication Date
NO975530D0 NO975530D0 (no) 1997-12-01
NO975530L true NO975530L (no) 1998-02-02
NO309091B1 NO309091B1 (no) 2000-12-11

Family

ID=26232004

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975530A NO309091B1 (no) 1995-06-02 1997-12-01 Oksazolidinonderivater, deres fremstilling samt medikament og farmasøytisk preparat inneholdende disse

Country Status (27)

Country Link
US (1) US5843975A (no)
EP (1) EP0835254B1 (no)
JP (1) JP3856829B2 (no)
KR (1) KR100457502B1 (no)
CN (1) CN1075072C (no)
AR (1) AR006301A1 (no)
AT (1) ATE184005T1 (no)
AU (1) AU699367B2 (no)
BR (1) BR9608896A (no)
CA (1) CA2223011C (no)
CO (1) CO4700462A1 (no)
CZ (1) CZ378497A3 (no)
DE (1) DE69604071T2 (no)
DK (1) DK0835254T3 (no)
ES (1) ES2138346T3 (no)
GR (1) GR3031710T3 (no)
HK (1) HK1014938A1 (no)
HU (1) HU224879B1 (no)
MX (1) MX9709410A (no)
NO (1) NO309091B1 (no)
NZ (1) NZ310487A (no)
PL (1) PL183919B1 (no)
RU (1) RU2164226C2 (no)
SK (1) SK281934B6 (no)
TW (1) TW360654B (no)
WO (1) WO1996038444A1 (no)
ZA (1) ZA964563B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1078632A1 (en) * 1999-08-16 2001-02-28 Sanofi-Synthelabo Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity
CA2438582C (en) * 2001-01-31 2012-06-26 Synaptic Pharmaceutical Corporation Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
ES2357502T3 (es) * 2001-09-26 2011-04-27 Pfizer Italia S.R.L. Derivados de aminoindazol activos como inhibidores de quinasa, procedimiento para su preparación y composiciones farmaceuticas que los contienen.
JP2009525318A (ja) * 2006-02-01 2009-07-09 ファイザー・プロダクツ・インク 抗菌剤としてのベンズイソオキサゾールオキサゾリジノン
WO2008120655A1 (ja) * 2007-03-30 2008-10-09 Institute Of Medicinal Molecular Design, Inc. Ｉ型１１βヒドロキシステロイド脱水素酵素阻害活性を有するオキサゾリジノン誘導体
EP2123159A1 (de) * 2008-05-21 2009-11-25 Bayer CropScience AG (1,2-Benzisothiazol-3-yl)(thio)carbamate und (1,2-Benzisothiazol-3-yl)(thio)oxamate und deren Oxidationsformen als Pestizide
CA2784753A1 (en) * 2009-12-18 2011-06-23 Janssen Pharmaceutica Nv Substituted aminothiazolone indazoles as estrogen related receptor-.alpha. modulators
EP2536716B1 (en) * 2010-02-17 2014-05-21 Janssen Pharmaceutica, N.V. Aminothiazolones as estrogen related receptor-alpha modulators
WO2016097355A1 (en) * 2014-12-19 2016-06-23 Ge Healthcare Limited Labelled oxazolidinone derivatives
DE102015012050A1 (de) * 2015-09-15 2017-03-16 Merck Patent Gmbh Verbindungen als ASIC-Inhibitoren und deren Verwendungen
RU2637643C1 (ru) * 2016-09-05 2017-12-05 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фундаментальной и клинической иммунологии" (НИИФКИ) Иммунодепрессант

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2653017B1 (fr) * 1989-10-17 1995-05-05 Delalande Sa Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique.
US5235063A (en) * 1989-10-17 1993-08-10 Delalande S.A. Process of preparing by condensation certain
US5196543A (en) * 1989-10-17 1993-03-23 Delalande S.A. 3-aryloxazolidinone derivatives, process for their preparation and their use in therapy
US5182296A (en) * 1989-10-26 1993-01-26 Tanabe Seiyaky Co., Ltd. Naphthyloxazolidone derivatives
FR2671350A1 (fr) * 1991-01-08 1992-07-10 Adir Nouveaux derives de benzisoxazole et de benzisothiazole, leur procede de preparation, et les compositions pharmaceutiques les renfermant.
WO1992014418A1 (fr) * 1991-02-20 1992-09-03 Yusaku Koda Articulateur

Also Published As

Publication number Publication date
CO4700462A1 (es) 1998-12-29
HU224879B1 (en) 2006-03-28
CN1191534A (zh) 1998-08-26
SK281934B6 (sk) 2001-09-11
HUP9901349A3 (en) 2000-02-28
WO1996038444A1 (fr) 1996-12-05
SK161497A3 (en) 1998-05-06
ES2138346T3 (es) 2000-01-01
NZ310487A (en) 1999-05-28
AR006301A1 (es) 1999-08-25
DE69604071D1 (de) 1999-10-07
CA2223011A1 (en) 1996-12-05
HUP9901349A2 (hu) 1999-08-30
RU2164226C2 (ru) 2001-03-20
DK0835254T3 (da) 2000-03-27
EP0835254A1 (fr) 1998-04-15
NO309091B1 (no) 2000-12-11
GR3031710T3 (en) 2000-02-29
JPH11507330A (ja) 1999-06-29
CN1075072C (zh) 2001-11-21
CA2223011C (en) 2007-01-09
KR19990022187A (ko) 1999-03-25
ATE184005T1 (de) 1999-09-15
AU699367B2 (en) 1998-12-03
TW360654B (en) 1999-06-11
DE69604071T2 (de) 2000-04-06
ZA964563B (en) 1996-12-12
NO975530D0 (no) 1997-12-01
EP0835254B1 (fr) 1999-09-01
KR100457502B1 (ko) 2005-09-05
MX9709410A (es) 1998-07-31
PL323673A1 (en) 1998-04-14
PL183919B1 (pl) 2002-08-30
BR9608896A (pt) 1999-06-29
CZ378497A3 (cs) 1998-04-15
US5843975A (en) 1998-12-01
HK1014938A1 (en) 1999-10-08
JP3856829B2 (ja) 2006-12-13
AU6128896A (en) 1996-12-18

Similar Documents

Publication Publication Date Title
DK0869126T3 (da) Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
NO954369L (no) Oksazolidindionderivater, deres fremstilling og anvendelse
DK0832104T3 (da) Dolastatinderivater, deres fremstilling og anvendelse
NO961160L (no) Cykliske forbindelser, deres fremstilling og anvendelse
NO980720D0 (no) Pyridazin-3-on-derivater, deres anvendelse og mellomprodukter for deres fremstilling
NO951095L (no) Tiazolidin- og oksazolidinderivater, deres fremstilling og medisinske bruk
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
NO924650D0 (no) Dialkoksy-pyridinyl-benzimidazolderivater, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse
DK1161434T3 (da) Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
NO961721D0 (no) 2-oksetanon-limingsmidler, deres fremstilling og bruk
NO955326D0 (no) Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse
NO955305L (no) Optisk aktive benzotiepinderivater, deres fremstilling og anvendelse
NO975020D0 (no) Azacykloalkanderivater, fremstilling derav og deres anvendelse i terapi
NO962477L (no) Benzamidderivater, deres fremstilling og deres terapautiske anvendelse
NO992676D0 (no) 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse
DK0835254T3 (da) Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse
NO20001934D0 (no) 3-Substituerte tetrahydropyridopyrimidinon-derivater, deres fremstilling og anvendelse
NO940130D0 (no) Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav
NO921563D0 (no) Terapeutisk aktive aminopyrimidinderivater, fremgangsmaatefor deres fremstilling og anvendelse derav
NO955242D0 (no) Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse
NO980471D0 (no) Benzensulfonamidderivater, fremstilling derav og terapautiske anvendelser derav
NO20000066D0 (no) 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasoeytiske anvendelse
NO982549D0 (no) 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav
NO950560D0 (no) Piperazinderivater, deres fremstilling og terapautiske anvendelse
NO992436D0 (no) N(imidazolylbutyl)benzensulfonamidderivater, deres fremstilling og terapeutiske anvendelse

Legal Events

Date Code Title Description
MK1K Patent expired